BioRestorative Therapies, Inc. (NASDAQ:BRTX) Sees Significant Decrease in Short Interest

BioRestorative Therapies, Inc. (NASDAQ:BRTX) was the recipient of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 66,900 shares, a decline of 10.1% from the November 15th total of 74,400 shares. Based on an average daily volume of 50,000 shares, the short-interest ratio is currently 1.3 days. Currently, 1.3% of the shares of the company are sold short.

BioRestorative Therapies Stock Performance

Shares of BRTX traded up $0.01 during mid-day trading on Monday, hitting $1.46. 12,222 shares of the company traded hands, compared to its average volume of 710,102. The stock has a 50-day moving average price of $1.55 and a two-hundred day moving average price of $1.62. BioRestorative Therapies has a 1 year low of $1.03 and a 1 year high of $3.67. The stock has a market cap of $10.10 million, a price-to-earnings ratio of -0.91 and a beta of 62.52.

BioRestorative Therapies (NASDAQ:BRTX) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.35) by $0.22. BioRestorative Therapies had a negative net margin of 2,697.08% and a negative return on equity of 98.49%. The firm had revenue of $0.23 million during the quarter, compared to analysts’ expectations of $0.30 million. On average, analysts forecast that BioRestorative Therapies will post -1.43 EPS for the current year.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.